Skip to main content

iShares Genomics Immunology and Healthcare ETF (IDNA)

NYSEARCA: IDNA · IEX Real-Time Price · USD
49.42 -0.31 (-0.62%)
Oct 22, 2021 4:00 PM EDT - Market closed
Assets$347.41M
NAV$49.63
Expense Ratio0.47%
PE Ratio27.74
Shares Out7.00M
Dividend (ttm)$0.09
Dividend Yield0.18%
Ex-Dividend DateJun 10, 2021
1-Year Return
-
Volume88,324
Open49.66
Previous Close49.73
Day's Range48.83 - 49.92
52-Week Low37.37
52-Week High55.55
Beta0.78
Holdings58
Inception DateJun 11, 2019

About IDNA

The investment seeks to track the investment results of the NYSE® FactSet® Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Asset ClassEquity
RegionGlobal
IssuerBlackRock iShares
Stock ExchangeNYSEARCA
Ticker SymbolIDNA
Index TrackedNYSE FactSet Global Genomics and Immuno Biopharma Index

Top 10 Holdings

46.94% of assets
NameSymbolWeight
ModernaMRNA6.21%
Intellia TherapeuticsNTLA5.49%
MERCKMRK.DE5.02%
BioNTech SEBNTX4.63%
EVOTECEVT.DE4.51%
SeagenSGEN4.41%
GENMABGMAB.CO4.25%
Sarepta TherapeuticsSRPT4.19%
Regeneron PharmaceuticalsREGN4.18%
BEIGENE LTD6160.HK4.03%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Jun 10, 2021$0.05215Jun 16, 2021
Dec 14, 2020$0.03621Dec 18, 2020
Jun 15, 2020$0.08367Jun 19, 2020
Dec 16, 2019$0.23706Dec 20, 2019
Full Dividend History

News

Take a Look at the Top-Performing Biotech ETFs YTD

The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.

Other symbols:BBHBIBIBBIEIH
3 weeks ago - Zacks Investment Research

How Are Genomics ETFs Responding to Q2 Earnings?

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

2 months ago - Zacks Investment Research

A Comprehensive Guide to Genomic ETFs

Genomic ETFs are expected to benefit from the favorable trends in the genomic editing space.

3 months ago - Zacks Investment Research

9 Best Biotech ETFs to Play High-Octane Trends

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

3 months ago - Kiplinger

Genomics ETFs Surge on a Major Breakthrough in CRISPR Study

The genomic-editing space has come under the spotlight with the release of encouraging data from a study assessing an in vivo CRISPR-based gene editing therapy candidate, NTLA-2001.

3 months ago - Zacks Investment Research

Dig Deep: The Market Megatrends You Cannot Afford to Miss

As investors re-allocate in 2021, it is critical to look past the headlines to the overarching themes that will propel our economy into the future. Investors cannot afford to miss developments like digi...

Other symbols:IRBO
7 months ago - ETF Trends

Best Biotech ETFs for Q2 2021

The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.

Other symbols:ARKGXBI
8 months ago - Investopedia

Top-Performing Biotech ETFs Amid the COVID-19 Crisis

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

Other symbols:ARKGBTECGNOMXBI
9 months ago - Zacks Investment Research

Megatrends To Invest In Now: 3 Best ETF Picks

BlackRock has identified five big trends that are here to stay for the long haul. Investors can get exposure to these drivers via 17 iShares ETFs.

Other symbols:ICLNIDRV
10 months ago - Investors Business Daily

Go Beyond Trends: Healthcare Megatrends with the IDNA ETF

ETF investors looking ahead to 2021 tend to seek out current trends, but the megatrends run much deeper. These are the large-scale undercurrents that can disrupt a whole sector.

10 months ago - ETF Trends

Best Biotech ETFs for Q1 2021

The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.

Other symbols:ARKGBTEC
11 months ago - Investopedia

ETF Strategies to Tap into Medical Breakthroughs, Healthcare Innovations

The election year and the coronavirus has highlighted the importance of an adaptive health industry that meets up with quickly changing times. Investors can also tap into this evolution in healthcare th...

Other symbols:IBB
11 months ago - ETF Trends

Why You Should Invest in Genomics ETFs

Genomics ETFs have surged of late; here's why

Other symbols:ARKGGNOM
1 year ago - Zacks Investment Research

Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

Other symbols:ARKGGNOMPBE
1 year ago - Zacks Investment Research

Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

1 year ago - Zacks Investment Research

Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

Other symbols:BBHBTECCNCRGERMIBBXBI
1 year ago - Zacks Investment Research

Why Small-Cap Biotech ETFs Are Good Long-Term Bets

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

Other symbols:BBCBTECIBBJ
1 year ago - Zacks Investment Research

Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

1 year ago - Zacks Investment Research

Top-Performing Biotechnology ETFs Amid Coronavirus Outbreak

From vaccine-related progress to development of cell therapies for the treatment of coronavirus, all kept the rally in the biotech sector alive.

Other symbols:ARKGBIBXBI
1 year ago - Zacks Investment Research

Invest in the Future With Megatrend ETFs

In this episode of ETF Spotlight, I speak with Jeff Spiegel, U.S. Head of Megatrends and International ETFs at BlackRock, about megatrend investing.

Other symbols:GILDIHAKIRBOMRNAREGN
1 year ago - Zacks Investment Research

Profit from the Genomics Market Momentum With These ETFs

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

Other symbols:ARKGGNOMPBE
1 year ago - Zacks Investment Research

3 ETFs For More Moderna Bets

Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.

Other symbols:BTECCNCR
1 year ago - Benzinga

ETF Edge: Big boost for energy ETF

CNBC's Bob Pisani breaks down the biggest exchange-traded funds moves.

Other symbols:IPOJETSXOP
1 year ago - CNBC Television

Healthcare & Biotech ETFs Digest GILD's Failure News: 5 Winners

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

1 year ago - Zacks Investment Research

2 Biotechnology ETFs That Could Be Good For Diversification

While biotech stocks are often too risky for many investors, with the coronavirus raging and the race for a vaccine in play, taking a look at some ETFs that contain biotech stocks that are making stride...

Other symbols:IBB
1 year ago - ETF Trends